# Photobiomodulation and Sericin in the Treatment of Second‐Degree Burns Induced in Wistar Rats

**Authors:** Lilian de Araújo Pradal, Mustafa Munir Mustafa Dahleh, Marina Prigol, Gustavo Petri Guerra, Celeste da Rocha Paiva, Thaís Caroline Schnaufer, Lucinéia de Fátima Chasko Ribeiro, Rose Meire Costa, Gladson Ricardo Flor Bertolini

PMC · DOI: 10.1111/wrr.70135 · Wound Repair and Regeneration · 2026-02-23

## TL;DR

This study tested how sericin and laser therapy help heal burns in rats, finding that combining them improves tissue repair and reduces inflammation.

## Contribution

The study introduces the combined use of sericin and photobiomodulation for burn healing, showing enhanced collagen and reduced oxidative stress.

## Key findings

- SER + PBM treatment showed the highest type I collagen scores and outperformed other treatments.
- Groups with PBM had reduced oxidative stress markers like TNF-alpha and thiobarbituric acid reactive substances.
- Collagen scores were significantly higher in SER, PBM, SUL + PBM, and SER + PBM groups compared to controls.

## Abstract

This study investigated the isolated and combined effects of sericin and low‐level laser photobiomodulation (PBM) on the healing of experimentally induced second‐degree burns in male Wistar rats. Sericin has previously been associated with enhanced fibroblast migration and improved reepithelialization, while PBM has shown anti‐inflammatory potential. To assess their therapeutic value, 60 rats were randomised into six groups: untreated control (CON), silver sulfadiazine (SUL), sericin cream (SER), PBM alone, SUL + PBM and SER + PBM. Burn injuries were produced using a heated metal instrument applied for 3 s, and animals were euthanized 14 days later. Macroscopic photography, photothermography and histomorphometric analyses were performed. Statistical tests using generalised linear models were set at p = 0.05. A significant temperature difference between initial (AV0) and follow‐up (AV1) evaluations was observed, although granulation tissue formation did not differ across groups. Collagen analysis revealed that SER, PBM, SUL + PBM and SER + PBM groups presented higher collagen scores than controls (p < 0.05). The SER + PBM treatment was particularly effective, showing the greatest proportion of type I collagen and statistical superiority over the other interventions (p < 0.05). Molecular evaluations demonstrated reduced levels of tumour necrosis factor alpha, thiobarbituric acid reactive substances and catalase, especially in groups receiving PBM in combination with either sericin or sulfadiazine, suggesting a decrease in oxidative stress. Overall, the results indicate that both sericin and PBM positively influence tissue repair, with combined therapy—particularly SER + PBM—yielding enhanced collagen deposition and biochemical markers consistent with improved healing. Further studies are warranted to clarify the underlying biological mechanisms driving these outcomes.

## Linked entities

- **Proteins:** Cat (Catalase)
- **Chemicals:** silver sulfadiazine (PubChem CID 441244)

## Full-text entities

- **Genes:** Cpox (coproporphyrinogen oxidase) [NCBI Gene 304024], Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Collagen [NCBI Gene 693056], Vegfa (vascular endothelial growth factor A) [NCBI Gene 83785] {aka VEGF-A, VEGF111, VEGF164, VPF, Vegf}, Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 59086] {aka Tgfb}, Eln (elastin) [NCBI Gene 25043] {aka RATTREL11, TREL11, Trela, Trela26}, Cat (catalase) [NCBI Gene 24248] {aka CS1, Cas1, Cat01, Catl, Cs-1}, Igf1 (insulin-like growth factor 1) [NCBI Gene 24482] {aka IGF}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, Ephb1 (Eph receptor B1) [NCBI Gene 24338] {aka Ephb2, Erk, elk}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}
- **Diseases:** necrotic (MESH:D009336), erythema (MESH:D004890), toxicity (MESH:D064420), ischemia (MESH:D007511), Burn injuries (MESH:D002056), cutaneous lesions (MESH:D009059), edema (MESH:D004487), Inflammatory (MESH:D007249), injuries (MESH:D014947), pain (MESH:D010146), skin lesions (MESH:D012871)
- **Chemicals:** alcohol (MESH:D000438), TBARS (MESH:D017392), formalin (MESH:D005557), ROS (MESH:D017382), petroleum jelly (MESH:D010577), ketamine hydrochloride (MESH:D007649), lipid (MESH:D008055), OH- (MESH:C031356), cetostearyl alcohol (MESH:C010405), bisabolol (MESH:C004497), dipyrone (MESH:D004177), picrosirius red (MESH:C009798), propylene glycol (MESH:D019946), Silver Sulfadiazine (MESH:D012837), malondialdehyde (MESH:D008315), HE (-), O2 - (MESH:D013481), H2O2 (MESH:D006861), polyunsaturated fatty acids (MESH:D005231), hydroxyproline (MESH:D006909), haematoxylin (MESH:D006416), glycerin (MESH:D005990), biotin (MESH:D001710), aldehyde (MESH:D000447), hydroxyl (MESH:D017665), water (MESH:D014867), propylparaben (MESH:C006068), free radicals (MESH:D005609), methylparaben (MESH:C015358), mineral oil (MESH:D008899), TA (MESH:D013635), MDAs (MESH:D015104), xylazine (MESH:D014991), paraffin (MESH:D010232), metal (MESH:D008670), lanolin (MESH:D007809), triethanolamine stearate (MESH:C015555), SUL (MESH:D013411)
- **Species:** Bombyx mori (domestic silkworm, species) [taxon 7091], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12927123/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12927123/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC12927123/full.md

---
Source: https://tomesphere.com/paper/PMC12927123